X4 enters commercial fold with FDA approval of rare disease drug Xolremdi aliu Mon, 04/29/2024 – 11:36 More: X4 enters commercial fold with FDA approval of rare disease drug Xolremdi Source: fierce
read moreWith sales still stagnant, BioMarin adds divestiture to list of options for gene therapy Roctavian zbecker Mon, 04/29/2024 – 11:12 More: With sales still stagnant, BioMarin adds divestiture to list of options for gene therapy Roctavian Source: fierce
read moreMerck KGaA, Huma collab bears fruit with launch of bladder cancer patient support app apark Mon, 04/29/2024 – 11:00 More: Merck KGaA, Huma collab bears fruit with launch of bladder cancer patient support app Source: fierce
read moreAstraZeneca, Daiichi tout Enhertu trial win in earlier, broader HER2-low breast cancer aliu Mon, 04/29/2024 – 10:43 More: AstraZeneca, Daiichi tout Enhertu trial win in earlier, broader HER2-low breast cancer Source: fierce
read moreFDA calls for adcomm to discuss Novo Nordisk’s filing for weekly insulin kdunleavy Mon, 04/29/2024 – 10:42 More: FDA calls for adcomm to discuss Novo Nordisk's filing for weekly insulin Source: fierce
read moreThe method has the potential to be used to deliver RNA to the bloodstream for a range of diseases More: KCL study reveals particles in cows’ milk effective for oral delivery of RNA drugs Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals